Common fragile sites are specific genomic loci that form constrictions and gaps on metaphase chromosomes under conditions that slow, but do not arrest, DNA replication. These sites have been shown to have a role in various chromosomal rearrangements in tumors. Different DNA damage response proteins were shown to regulate fragile site stability, including ataxia-telangiectasia and Rad3-related (ATR) and its effector Chk1. Here, we investigated the role of ataxia-telangiectasia mutated (ATM), the main transducer of DNA double-strand break (DSB) signal, in this regulation. We demonstrate that replication stress conditions, which induce fragile site expression, lead to DNA fragmentation and recruitment of phosphorylated ATM to nuclear foci at DSBs. We further show that ATM plays a role in maintaining fragile site stability, which is revealed only in the absence of ATR. However, the activation of ATM under these replication stress conditions is ATR independent. Following conditions that induce fragile site expression both ATR and ATM phosphorylate Chk1, suggesting that both proteins regulate fragile site expression probably via their effect on Chk1 activation. Our findings provide new insights into the interplay between ATR and ATM pathways in response to partial replication inhibition and in the regulation of fragile site stability.
Introduction
Common fragile sites are specific chromosomal loci that appear as constrictions or gaps on metaphase chromosomes following conditions that slow, but do not arrest, DNA replication. These sites are an intrinsic part of the normal chromosome and are considered to be present in all individuals. About 90 common fragile sites were cytogenetically identified in the human genome . Studies in cell cultures have shown that under replication stress conditions fragile sites are hotspots for sister chromatid exchange, translocations and deletions (Glover and Stein, 1987; Glover and Stein, 1988; Wang et al., 1997) . In vivo, fragile sites correlate with chromosomal breakpoints in tumors (Hecht and Hecht, 1984; Yunis and Soreng, 1984) and with integration sites of oncogenic viruses (Thorland et al., 2003; Bester et al., 2006) .
The major inducer of common fragile sites is aphidicolin, an inhibitor of DNA polymerases a, d and e (Ikegami et al., 1978; Cheng and Kuchta, 1993) . Under replication stress conditions, conferred by low concentrations of aphidicolin, the replication along fragile regions is specifically perturbed and in a substantial fraction of G2 cells, the fragile regions fail to complete their replication (Le Beau et al., 1998; Hellman et al., 2000) . However, the molecular events leading from replication perturbation to gaps and constriction on metaphase chromosomes are still largely unknown.
Studies aiming to shed light on the mechanism leading to fragility, showed the involvement of different cell cycle checkpoint and DNA repair proteins in the regulation of fragile site stability. The first checkpoint protein implicated in fragile site stability was ataxiatelangiectasia and Rad3-related (ATR). ATR plays a central role in the checkpoint response to agents that block replication fork progression (Abraham, 2001) . Downregulation of ATR results in increased instability at fragile site following replication stress, and even under normal growth conditions (Casper et al., 2002) . Subsequently it has been shown that other proteins involved in cell cycle checkpoints and DNA repair, such as BRCA1, SMC1 and FANCD2, play a role in maintaining fragile site stability (reviewed by Arlt et al., 2006) . Recently, Chk1, the main effector in ATR transduction pathway was also shown to have a role in the regulation of fragile site stability . In addition, we have demonstrated the involvement of proteins from the DNA double-strand break (DSB) repair pathways, homologous recombination (HR) and non-homologous end joining (NHEJ), in the repair and stability of fragile sites, raising the possibility that DSBs are formed specifically at fragile sites (Schwartz et al., 2005) . These results support a model by which under partial replication stress conditions, while the replication of the entire genome is slowed, the replication along fragile regions is specifically perturbed leading to collapse of stalled replication forks and the formation of DSBs.
The primary transducer of DSB signal is ataxiatelangiectasia mutated (ATM). Like ATR, ATM activates a checkpoint pathway crucial for the cellular response to DNA damage (Bakkenist and Kastan, 2004) . In response to DSB formation, ATM is rapidly activated and phosphorylates various substrates each of which is a key factor in the damage response pathway (Shiloh, 2006) .
We provide direct evidence that partial replication stress, which induces fragile site expression leads to DNA fragmentation, indicating DSB formation. These replication-induced DSBs, lead to ATM activation and recruitment to nuclear foci that colocalize with foci of the DSB marker, phosphorylated histone H2AX (gH2AX). We further show that ATM plays a role in maintaining fragile site stability, which is revealed in the absence of ATR. However, the activation of ATM under these replication stress conditions is ATR independent. Furthermore, following conditions that induce fragile site expression both ATR and ATM phosphorylate Chk1, suggesting that both proteins regulate fragile site expression probably via their effect on Chk1 activation.
Results
Conditions which induce gaps and constrictions at fragile sites lead to DNA fragmentation ATM is the main transducer in the checkpoint response to DSBs. Aiming to study its possible role in replication stress response, we directly examined the formation of DSBs under conditions that induce fragile site expression, using pulsed field gel electrophoresis (PFGE). Under complete replication inhibition a substantial fraction of the forks is likely to collapse, hence small DNA fragments are expected. Under partial replication inhibition most of the forks will slow down but will not arrest. If under these conditions a small fraction of the replication forks will arrest and collapse leading to DSBs, larger DNA fragments are expected. The results showed aphidicolin-induced DNA fragmentation following both partial (0.4 mM) and complete (10 mM) replication inhibition ( Figure 1a) . Most of the DNA fragments resulting from replication arrest (10 mM) were o1 Mb in size. Large DNA fragments (>1.9 Mb) were observed only following 0.4 mM aphidicolin (Figure 1b) , suggesting that the stress conferred by partial replication inhibition resulted in less frequent DSBs. This fragmentation is not associated with apoptosis as we found that the aphidicolin treatments we have used do not lead to apoptosis (Supplementary Figure S1) .
ATM is phosphorylated and its phosphorylated form colocalizes with gH2AX at nuclear foci under conditions that induce gaps and constriction at fragile sites We further investigated the possibility that the DSBs formed by 0.4 mM aphidicolin lead to ATM activation. ATM undergoes autophosphorylation on Ser1981 in response to various stress conditions including ionizing radiation (IR) and replication arrest conferred by thymidine (Bakkenist and Kastan, 2003; Bolderson et al., 2004) . Western blot analysis using an antibody directed against ATM phosphorylated on Ser1981 (ATM pS-1981) showed that ATM is phosphorylated following partial replication perturbation conferred by 0.4 mM aphidicolin (Figure 2a) . The pS-1981 band was abolished by phosphatase treatment (Supplementary Figure S2) . Interplay between ATM and ATR in fragile site regulation E Ozeri-Galai et al
It is well established that ATM kinase activity is enhanced by DSBs (Banin et al., 1998; Canman et al., 1998) , however, ATM was also shown to be phosphorylated in the absence of visible DSBs, for example, following replication arrest by thymidine (Bolderson et al., 2004) . Previous studies have shown that following DSBs phosphorylated ATM forms nuclear foci, whereas following alterations in the chromatin structure without detectble DSBs, a diffused staining across the nucleus is observed (Bakkenist and Kastan, 2003) . Immunostaining showed that phosphorylated ATM formed discrete nuclear foci following 0.4 mM aphidicolin treatment indicating the existence of DSBs (Figure 2b) .
We then investigated the colocalization of ATM with gH2AX, which is known to localize to DSBs and to expressed fragile sites (Rogakou et al., 1998; Rogakou et al., 1999; Schwartz et al., 2005) . The analysis showed that the majority of the phosphorylated ATM foci (91%) colocalized with gH2AX foci (Figure 2c ). These results strongly suggest that the DSBs formed following conditions that induce fragile site expression leading to ATM activation. Furthermore, ATM is recruited to foci which probably represent replication stress-induced DSBs.
ATM has a role in the regulation of fragile site stability The activation of ATM under conditions that induce fragile site expression might suggest that ATM plays a role in the stability of these sites. To investigate this hypothesis we analysed fragile site expression in fibroblasts from an AT patient, in which the ATM protein is almost completely absent and in the same cells complemented with the normal ATM cDNA. In these cells the level of the ATM protein is relatively high (Figure 3a ) and the protein is functional (Ziv et al., 1997) . First we analysed the total number of gaps and constrictions on metaphase chromosomes. Following 24 h treatment with 0.4 mM aphidicolin a small increase in the number of gaps and constrictions was found in AT cells, however this difference was not statistically significant (P>0.05; Figure 3b ). Next, we analysed the frequency of gaps and constrictions at specific fragile sites using fluorescent in situ hybridization (FISH) with specific probes from the cloned common fragile sites FRA3B and FRA7G (Supplementary Figure S3) . No difference was found in the expression level of these sites between AT and AT complemented cells ( Figure 3c ). These results are in agreement with a previous study which found no difference in the frequency of gaps and constrictions at fragile sites between AT and normal lymphoblast cell lines (Casper et al., 2002) .
Since ATM is activated in response to replication stress conferred by aphidicolin, we hypothesized that the fact that its absence does not have a significant effect on fragile sites could be explained by an overlap between ATR and ATM functions. In order to test this hypothesis we analysed fragile site expression in the absence of ATM (ATM
. For this AT and AT complemented cells were transiently transfected with short interfering RNA (siRNA) directed against ATR mRNA (si-ATR) ( Figure 4a ). Partial replication inhibition conferred by low concentrations of aphidicolin had a major effect in ATM À /ATR À cells, resulting in chromosome fragmentation. Metaphases were divided into three groups, according to the level of chromosome fragmentation: metaphases harboring o100 gaps and constrictions (o100), metaphases in which chromosomes structures were still visible (fragmented) and metaphases in which chromosomes were completely shattered (highly fragmented) (Figure 4b ). Following 0.4 mM aphidicolin treatment, in 60% of the ATM À /ATR À cells, highly fragmented metaphases were found, while in ATM þ / ATR À cells, the fraction of such metaphases was significantly lower (22%) (Po0.005). Treatment with a lower aphidicolin concentration (0.1 mM) also showed increased chromosome fragmentation in ATM (Figure 4c ). In the presence of ATR no highly fragmented metaphases were observed, following either 0.1 or 0.4 mM aphidicolin (data not shown). These results clearly show that ATM has a role in maintaining genome stability following replication stress, which is revealed only in the absence of ATR.
We further analysed the role of ATM in fragile site stability under normal growth conditions. ATR Interplay between ATM and ATR in fragile site regulation
) resulted in fragile site expression in agreement with previous results (Casper et al., 2002) . A significant increase in the number of gaps and constrictions was observed in cells lacking both ATM and ATR compared to cells deficient in ATR alone (Po0.05). Most of the metaphases in these cells (B80%) had >2 gaps and constrictions and a new group of metaphases showing a high number of gaps and constrictions (>16) was observed (Figure 5a) (Figure 5b) . Altogether, the results clearly show that in addition to ATR, ATM also plays a role in maintaining fragile site stability.
Independent activation of ATM and ATR pathways under conditions that induce fragile site expression ATR and ATM transduction pathways were previously considered as two parallel pathways, IR induces the ATM pathway, whereas replication stress activates the ATR pathway. However, recently the regulation of ATM and ATR was shown to be dependent one on the other in response to different DNA damaging conditions including IR, UV light and replication stalling by Hydroxyurea (HU) (Jazayeri et al., 2006; Myers and Cortez, 2006; Stiff et al., 2006; Cuadrado et al., 2006b; Yoo et al., 2007) . Since 0.4 mM aphidicolin treatment activates both ATR and ATM pathways, we analysed whether under these conditions the activation of these proteins depends on each other. First we analysed ATM phosphorylation in cells downregulated for ATR. As can be seen in Figure 6a , following 0.4 mM aphidicolin treatment, ATM was phosphorylated and formed nuclear foci in cells in which the ATR protein was downregulated. Thus, under these conditions the activation of ATM is ATR independent.
In order to investigate the dependency of ATR activation on ATM we analysed the staining of Replication Protein A (RPA) in AT cells using an anti-RPA34 antibody. RPA is a protein complex that associates with single-stranded DNA (ssDNA) and is required for the recruitment of ATR-ATRIP complex to DNA damage. Moreover, the presence of RPA on ssDNA is sufficient to recruit ATR-ATRIP complex to DNA (Zou and Elledge, 2003) . Thus, RPA was used as an indication for the induction of the ATR pathway. The results showed RPA focus formation in AT cells. Thus, under partial replication perturbation conferred by aphidicolin ATM is not required for RPA recruitment to sites of DNA damage, which might indicate that the regulation of the ATR pathway is ATM independent. Altogether, our results indicate that under partial replication stress conferred by aphidicolin there is independent activation of ATM and ATR pathways.
Both ATR and ATM activate Chk1 under conditions that induce fragile site expression ATR and ATM have two major effectors; Chk1 and Chk2 respectively (Abraham, 2001 ). Recently, Durkin Interplay between ATM and ATR in fragile site regulation E Ozeri-Galai et al et al. showed that Chk1 but not Chk2 regulates common fragile site stability ). Since we found that ATM is phosphorylated following replication stress and plays a role in regulating fragile site stability, we hypothesized that this effect of ATM might be transduced by Chk1. Chk1 is activated by phosphorylation of several residues, including Ser345. Western blot analysis using an antibody directed against the phosphorylated Ser345 showed that in ATM þ /ATR þ cells Chk1 is activated in response to replication stress conferred by 0.4 mM aphidicolin (Figure 6c (Figure 6c ). These results clearly show that Both ATR and ATM phosphorylate Chk1 under conditions that induce fragile site expression.
Discussion
The results presented in this study show that under replication stress conditions that induce fragile site expression, ATM is activated and recruited to DSB-induced Interplay between ATM and ATR in fragile site regulation E Ozeri-Galai et al nuclear foci. Moreover, we show that together with ATR, ATM plays a role in the regulation of fragile site stability via activation of Chk1. Fragile sites were suggested to be involved in different DSB-induced chromosomal aberrations found in many tumor types (Richards, 2001; Arlt et al., 2003) , including deletions, translocations and oncogene amplification. Here we show that treatment with 0.4 mM aphidicolin, which induce fragile site expression, leads to DNA fragmentation, providing a direct evidence for DSBs formation under these conditions (Figure 1 ). Under the same conditions ATM, the primary transducer of DSBs, is phosphorylated and recruited to foci which colocalize with gH2AX (Figure 2 ). We further demonstrate that ATM plays a role in maintaining fragile site stability (Figure 4) . These results provide clear evidence that DSB formation is part of the mechanism leading to fragile site expression and are consistent with our previous findings showing that proteins from the HR and NHEJ DSB repair pathways are important for maintaining fragile site stability (Schwartz et al., 2005) . Recent studies found frequent allelic imbalances at common fragile sites, in early stages of tumor development (Bartkova et al., 2005; Gorgoulis et al., 2005) . In addition, overexpression of oncogenes, was shown to result in replication stress and replication-dependent DSBs formation (Bartkova et al., 2006; Di Micco et al., 2006) . Our results together with results from previous studies suggest that during cancer development replication stress conditions specifically perturb replication along fragile regions leading to DSB formation which result in chromosomal instability at these sites.
Recent studies have shown that the regulation of ATM and ATR can depend one on the other. Following IR, ATR regulation was shown to be ATM dependent. Under these conditions, in the absence of ATM, RPA is not recruited to the damaged DNA, a crucial event for ATR recruitment (Jazayeri et al., 2006; Myers and Cortez, 2006; Cuadrado et al., 2006b) . Another study showed that following UV and replication arrest by HU, ATM phosphorylation is ATR dependent (Stiff et al., 2006) . Our results show that under partial replication stress induced by 0.4 mM aphidicolin, ATM is phosphorylated in cells downregulated for the ATR protein and RPA focus formation is ATM independent (Figures 6a and b) . These results suggest that ATM and ATR pathways are independently activated under conditions that induce fragile site expression. In agreement with these results we demonstrate a synergistic effect of ATR and ATM in the regulation of fragile site stability. The lack of increased fragile site expression in ATM deficient cells relative to ATM complemented cells may be explained by a few explanations: (1) ATM is required for the repair of DNA damage at fragile sites only in the absence of ATR, since ATR has a role in preventing DSB formation as a result of replication fork stalling (Brown and Baltimore, 2003) . This explanation is unreasonable since under replication stress conditions in ATM þ /ATR þ cells both DNA fragmentation (Figure 1 ) and ATM phosphorylation (Figure 2 ) were observed. (2) In the absence of ATM, ATR compensate for its function. This hypothesis is supported by a recent report showing that following replication arrest by HU, the absence of ATM leads to an increased loading of ATR to chromatin (Cuadrado et al., 2006a) . Interplay between ATM and ATR in fragile site regulation E Ozeri-Galai et al Similar to the overlap between the ATR and ATM functions in maintaining fragile site stability, we demonstrate an overlap between these two proteins in the regulation of Chk1 phosphorylation, under conditions that induce fragile site expression (Figure 6 ). Recently it was shown that downregulation of the Chk1 kinase has a major effect on fragile site stability , hence the effect of ATM on the level of Chk1 phosphorylation is probably part of the mechanism by which ATM regulates fragile site expression. It is worth noting that in addition to Chk1, other shared targets of ATR and ATM (BRCA1, SMC1 and FANCD2) (Gatei et al., 2001; Kim et al., 2002; Ho et al., 2006) were also shown to regulate fragile site stability (reviewed by Arlt et al., 2006) . Further studies are required to investigate the regulation of these proteins by ATR and ATM, under conditions that induce fragile site expression.
A previous study by Durkin et al. showed that Chk2 is activated under conditions that induce fragile site expression. However, Chk2 downregulation had no effect on fragile site stability; moreover, downregulation of both Chk1 and Chk2 had a similar effect to the downregulation of Chk1 alone. Hence, under these conditions, the phosphorylation of Chk2 might have other roles in checkpoint response.
The role of ATR in DNA replication and in replication stress response is well established. Mec1, the yeast ATR homolog, is essential for stabilization of stalled replication forks (Lopes et al., 2001; Tercero and Diffley, 2001) . In mammalian cells, ATR was shown to be important in preventing DSB formation at stalled replication forks (Brown and Baltimore, 2003) . In agreement with ATR being the major kinase in the replication stress response, our results show that ATR has a more significant effect on fragile site stability than ATM. Replication stress might result in different types of DNA damage at fragile sites such as stalled replication forks, single strand breaks and DSBs. Our results suggest that ATR is sufficient for the signaling of all types of DNA damage generated at fragile sites. It is possible that ATM is important mostly for the signaling of DSBs generated at these sites. Interplay between ATM and ATR in fragile site regulation E Ozeri-Galai et al In summary, we show a role for ATM and an interplay between ATR and ATM pathways in maintaining the stability of fragile sites. These results are important for understanding the cellular response to conditions of partial replication inhibition and the mechanisms leading to fragile site instability in cancer development.
Materials and methods

Cells, growth conditions and treatments
HeLa, U2OS and GM000847 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (FCS). AT22IJE-T fibroblasts expressing either empty vector or full-length ATM cDNA were described previously (Ziv et al., 1997) . Aphidicolin treatment was performed in M-199 media supplemented with 10% FCS containing the indicated aphidicolin concentration and 0.5% ethanol.
Western blot analysis
Polyacrylamide gels were used for protein separation for detection of ATR/ATM (6%) and Chk1 (12%). The primary antibodies used in this analysis were goat anti-ATR (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), rabbit antiphosphorylated S1981 ATM (Bethyl Laboratories, Inc., Montgomery, TX, USA), mouse anti-ATM kindly provided by Y Shiloh (Tel-Aviv university, Tel Aviv, Israel), rabbit antiphosphorylated S345 Chk1 and rabbit anti-Chk1 (Cell Signaling Technology, Danvers, MA, USA). HRP-conjugated anti-mouse, anti-rabbit and anti-goat secondary antibodies were obtained from Jackson Immunoresearch Laboratories (West Grove, PA, USA).
Immunofluorescence
For pS1981 ATM cells were fixed in methanol for 15 min, permeabilized with Acetone and blocked with 2% bovine serum albumin (BSA)/phosphate-buffered saline (PBS). For gH2AX and RPA34 cells were fixed in 4% formaldehyde for 10 min, permeabilized with 0.5% TritonX-100 for 10 min and blocked with 10% BSA/PBS. The primary antibodies used in this analysis were mouse anti-pS1981 ATM (Cell Signaling Technology), rabbit anti-gH2AX (Upstate Biotechnology, Lake Placid, NY, USA) and mouse anti-RPA34 (Calbiochem, San Diego, CA, USA). Appropriate Cy3 or Cy2 conjugated secondary antibodies were added (Jackson Immunoresearch Laboratories). Images were taken with a Bio-Rad confocal microscope. For focus information analysis at least 50 nuclei for each condition were analysed.
Chromosome preparation and fragile site analysis Cells were harvested after a 40-min treatment with 100 ng ml À1 colchicine followed by a 40-min incubation in 0.4% KCl at 37 1C and multiple changes of 3:1 methanol:acetic acid fixative. Cells were dropped onto slides and slides were baked overnight at 37 1C before the FISH protocol. Clones 1O12 and V203C were used for FRA3B and FRA7G, respectively. Probes were labeled as previously described (Schwartz et al., 2005) . FISH on metaphase chromosomes was performed as previously described (Lichter et al., 1988) .
Gaps and constrictions at fragile sites were analysed using a Nikon fluorescent microscope. For total gaps and constrictions, at least 50 metaphases for each condition were analysed. For expression of specific fragile sites, at least 50 hybridizations were analysed.
RNA interference
The siRNA sequence directed against ATR was constructed by IDT (Coralville, IA, USA). siRNA-2 sequence was described previously (Casper et al., 2002) . Nonspecific control oligo (Dharmacon, Lafayette, CO, USA) contains 52% GC content similar to the GC content in the specific oligo. Oligofectamine (Invitrogen, Carlsbad, CA, USA) was used for transfection of these RNA oligos into AT22IJE-T cells. Aphidicolin treatment was performed 72 h post-transfection.
Statistical analysis
For comparison of total gaps and constrictions and foci number, the Kolmogorov-Smirnov two-sample test was used. For comparison of the frequency of gaps and constrictions at specific fragile sites, Fisher's test was used.
Pulsed filed gel electrophoresis
Following 24 h treatment with the indicated aphidicolin concentrations, cells were harvested, and 10 6 cells were melted into each agarose insert. The agarose inserts were incubated in 0.5 M ethylenediaminetetraacetic acid (EDTA), 1% sodium dodecyl sulfate-proteinase K (250 mg ml À1 ) at 50 1C for 48 h and thereafter washed three times in 50 mM EDTA buffer prior to loading onto a 0.9% agarose gel and separated by PFGE for 90 h (Bio-Rad CHEF-DR II, 1400 s switch time, 2 V cm À1 ). The gel was subsequently stained with ethidium bromide and analysed with ImageJ software.
